Novo Nordisk
NVO
NVO
550 hedge funds and large institutions have $7.99B invested in Novo Nordisk in 2018 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 162 increasing their positions, 196 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
550
Holders Change
-8
Holders Change %
-1.43%
% of All Funds
12.27%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.27%
New
74
Increased
162
Reduced
196
Closed
77
Calls
$78.1M
Puts
$32.3M
Net Calls
+$45.8M
Net Calls Change
-$11.3M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$195M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$100M |
| 3 |
Renaissance Technologies
New York
|
+$49.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.1M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$18.8M |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$46.2M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$30.9M |
| 3 |
BlackRock
New York
|
-$25.9M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$22.6M |
| 5 |
LIM
Lagoda Investment Management
New York
|
-$15.4M |
